Article

Safety profile of rivaroxaban in first-time users treated for venous thromboembolism (deep vein thrombosis and pulmonary embolism) in four European countries

2023-04-17

Abstract excerpt

<h4>Background: </h4> The European rivaroxaban post-authorization safety study evaluated bleeding risk among patients initiated on rivaroxaban or vitamin K antagonists for the treatment and secondary prevention of venous thromboembolism in routine clinical practice. <h4>Methods: </h4> Cohorts were created using healthcare databases from the UK, the Netherlands, Germany and Sweden. Patients given a first prescripti...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f70c2d3d-c002-5a6c-990a-3a1a075518af
DOI: 10.21203/rs.3.rs-2664836/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Safety profile of rivaroxaban in first-time users treated for venous thromboembolism (deep vein thrombosis and pulmonary embolism) in four European countriesDOI 10.21203/rs.3.rs-2664836/v1Read

INCIDENCE OF VENOUS THROMBOTIC EVENTS AND EVENTS OF SPECIAL INTEREST IN A RETROSPECTIVE COHORT OF COMMERCIALLY-INSURED US PATIENTSSemantic proximity Read

Diagnosis and management of venous thromboembolism: an update a decade into the new millennium.Semantic proximity Read

Bleeding with anticoagulation therapy - who is at risk, and how best to identify such patients.Semantic proximity Read

Direct oral anticoagulants in patients with severe inherited thrombophilia: a single-center cohort study.Semantic proximity Read

Gastrointestinal Bleeding During Direct Oral Anticoagulants Therapy in Patients With Nonvalvular Atrial Fibrillation and Risk of PolypharmacySemantic proximity Read

Effectiveness and Safety of Anticoagulants Among Patients with Venous Thromboembolism and Active Cancer Who Also Had Prior Bleed or Prior Renal DiseaseSemantic proximity Read

Cohort Profile: The Danish Venous Thromboembolism Cohort – A Linkage Between Danish National Health Surveys and Health RegistersSemantic proximity Read

An ADR pharmaceutical care for severe gastrointestinal bleeding of rivaroxaban in a patient with non-valvular atrial fibrillation based on TDM and genetic testingSemantic proximity Read

A Pilot Randomized Study of Atorvastatin As Adjunct Therapy in Patients with Acute Venous ThromboembolismSemantic proximity Read

Risk Factors for Rivaroxaban-Related Bleeding Events—Possible Role of Pharmacogenetics: Case SeriesSemantic proximity Read

Background rates of hospitalizations and emergency department visits for selected thromboembolic and coagulation disorders in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillanceSemantic proximity Read

Prediction of Venous Thromboembolism Based on Clinical and Genetic FactorsSemantic proximity Read